leukotriene B3: RN given refers to (R-(R*,S*-(E,Z,E)))-isomer; structure given in first source [MeSH]
LTB3 : no description available [CHeBI]
| ID Source | ID |
|---|---|
| PubMed CID | 6439476 |
| CHEBI ID | 189035 |
| MeSH ID | M0132828 |
| Synonym |
|---|
| 6,8,10-eicosatrienoic acid, 5,12-dihydroxy-, (r-(r*,s*-(e,z,e)))- |
| leukotriene b3 |
| 88099-35-8 |
| CHEBI:189035 |
| (5r,6e,8z,10e,12s)-5,12-dihydroxyicosa-6,8,10-trienoic acid |
| ltb3 |
| cid 6439476 |
| Class | Description |
|---|---|
| hydroxy fatty acid | Any fatty acid carrying one or more hydroxy substituents. |
| polyunsaturated fatty acid | Any fatty acid containing more than one double bond. Acids in this group are reported to have cardioprotective effects; and levels are lowered in chronic fatigue syndrome. |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 6 (85.71) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| Condition | Indicated | Studies | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
|---|